Benzinga's Top Pre-Market Gainers
ACADIA Pharmaceuticals (NASDAQ: ACAD) moved up 149.57% to $5.74 in the pre-market session. ACADIA Pharmaceuticals reported successful top-line results from its pivotal Phase III Parkinson's disease psychosis trial.
Crocs (NASDAQ: CROX) added 5.26% to $13 in the pre-market session. Crocs' PEG ratio is 0.90.
Amarin Corporation plc (NASDAQ: AMRN) soared 3.22% to $11.86 in the pre-market trading. Amarin announced the US patent 8,318,715 issuance for Vascepa.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.